Log In
Print this Print this

IVR 102

  Manage Alerts
Collapse Summary General Information
Company Ivrea Pharmaceuticals Inc.
DescriptionTopical fungicide
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationOnychomycosis
Indication DetailsTreat onychomycosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today